Kyrtsonis, M., Sarris, K., Koulieris, E., Maltezas, D., Nikolaou, E., Angelopoulou, M. K., . . . Panayiotidis, P. (2014). Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. Hindawi Publishing Corporation.
Citação norma ChicagoKyrtsonis, Marie-Christine, et al. Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. Hindawi Publishing Corporation, 2014.
Citação norma MLAKyrtsonis, Marie-Christine, et al. Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia. Hindawi Publishing Corporation, 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.